Matches in Nanopublications for { ?s ?p "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP208946.RAXXmc_tWRsn93szJixuR4dpqXo-UOlGH4ZhoFRW7dEEU130_assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208946.RAXXmc_tWRsn93szJixuR4dpqXo-UOlGH4ZhoFRW7dEEU130_provenance.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_provenance.
- assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.